Arterial hypertension is a major risk factor for cerebrovascular diseases, increasing the likelihood of both ischemic and hemorrhagic events at the cerebral level. Vascular damage induced by elevated blood pressure alters cerebral perfusion, leading to progressive endothelial dysfunction, arterial stiffness, and reduced capacity for autoregulation of blood flow.
Alterations in the regulation of cerebral blood flow
Arterial hypertension profoundly impairs the ability of cerebral vessels to autoregulate blood flow, making the brain more vulnerable to blood pressure fluctuations.
Altered autoregulation: in normotensive individuals, cerebral blood flow remains relatively constant thanks to the ability of vessels to dilate or constrict in response to pressure changes. In chronic hypertension, this capacity is progressively lost, increasing the risk of hypoperfusion or hyperperfusion in the event of blood pressure oscillations.
Risk of hypoperfusion: following sudden reductions in arterial pressure, the brain may experience episodes of hypoperfusion, with transient neurological deficits and syncope.
Risk of hypertensive encephalopathy: during hypertensive crises, the loss of vascular autoregulation can cause diffuse cerebral edema, with severe headache, confusion, altered mental status, and, in the most severe cases, coma.
These alterations make the hypertensive brain more susceptible to acute and chronic vascular damage, emphasizing the importance of effective blood pressure control for the prevention of neurological complications.
Major cerebrovascular events
Cerebrovascular events are among the most feared complications of arterial hypertension. The main cerebrovascular event associated with hypertension is stroke, which can be either ischemic or hemorrhagic:
Ischemic stroke: in most cases, it is related to the progression of cerebral atherosclerosis and the formation of thrombi that occlude cerebral vessels. Hypertension contributes to the formation and instability of atherosclerotic plaques, increasing the risk of arterial thrombosis or embolism.
Hemorrhagic stroke: high blood pressure increases parietal stress on cerebral arterioles, favoring the formation and rupture of Charcot-Bouchard microaneurysms, particularly in the regions of the basal ganglia, thalamus, pons, and cerebellum.
Major vascular events may leave permanent disabling sequelae, such as motor deficits, aphasia, and cognitive deterioration, with a significant impact on the patient’s quality of life.
Leukoaraiosis and vascular dementia
Beyond strokes, hypertension is responsible for more insidious and progressive cerebral changes, which may go unnoticed until advanced stages.
Leukoaraiosis: this is a chronic diffuse injury of the subcortical white matter, visible on MRI as hyperintense areas, resulting from repeated clinically silent microischemic events. It is strongly associated with hypertension and small vessel disease.
Vascular dementia: the progressive accumulation of ischemic cerebral injury impairs cognitive functions, leading to cognitive decline, memory disturbances, and executive dysfunction. Hypertension is one of the leading causes of vascular dementia.
The impairment of cerebral microcirculation and the cumulative effect of small lacunar infarcts contribute to a progressive reduction in cognitive and functional capacities in hypertensive patients.
Conclusion
The cerebral complications of arterial hypertension include both acute ischemic events, such as stroke, and progressive chronic damage, such as leukoaraiosis and vascular dementia. Maintaining adequate blood pressure control and managing cardiovascular risk factors are fundamental strategies to prevent brain damage and its long-term consequences.
References
Wright CB, et al. Impact of Hypertension on Cognitive Function. J Clin Hypertens. 2019;21(3):107-115.
Chrysant SG. The Impact of Hypertension on Cerebral Circulation and Cognition. J Clin Hypertens. 2018;20(2):60-66.
Iadecola C, Yaffe K, et al. Hypertension and Brain Dysfunction. Hypertension. 2016;68(3):12-18.
Gorelick PB, et al. Vascular Contributions to Cognitive Impairment and Dementia. Stroke. 2011;42(9):2672-2713.
Williams B, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-3104.
Whelton PK, et al. 2017 ACC/AHA Hypertension Guidelines. J Am Coll Cardiol. 2018;71(19):e127-e248.
Qureshi AI, et al. Hypertension and stroke: epidemiology, pathophysiology, and management. Curr Atheroscler Rep. 2015;17(6):527.
Del Bene A, et al. Leukoaraiosis and small vessel disease: clinical implications. J Neurol Sci. 2018;389:12-21.
Rost NS, et al. White matter hyperintensities and cognitive decline. Stroke. 2015;46(4):1145-1151.
Roman GC, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43(2):250-260.
